Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries
Linas, B.P.
Journal of Infectious Diseases 212(4): 513-515
2015
ISSN/ISBN: 1537-6613 PMID: 25767215 DOI: 10.1093/infdis/jiv041Document Number: 640318
Document emailed within 0-6 h
Related Documents
Cambiano, V.; Ford, D.; Mabugu, T.; Napierala Mavedzenge, S.; Miners, A.; Mugurungi, O.; Nakagawa, F.; Revill, P.; Phillips, A. 2015: Assessment of the Potential Impact and Cost-effectiveness of Self-Testing for HIV in Low-Income Countries Journal of Infectious Diseases 212(4): 570-577Harmon, T.M.; Fisher, K.A.; McGlynn, M.G.; Stover, J.; Warren, M.J.; Teng, Y.; Näveke, A. 2016: Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries Plos one 11(1): E0146387
Hughes, N.; Arora, M.; Grills, N. 2016: Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature Bmj Open 6(3): E010391
Hughes, N.; Arora, M.; Grills, N. 2016: Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature Bmj Open 6(3): E010391
Hughes, N.; Arora, M.; Grills, N. 2016: Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature Bmj Open 6(3): E010391
Hughes, N.; Arora, M.; Grills, N. 2016: Perceptions and impact of plain packaging of tobacco products in low and middle income countries, middle to upper income countries and low-income settings in high-income countries: a systematic review of the literature Bmj Open 6(3): E010391
Mangham-Jefferies, L.; Pitt, C.; Cousens, S.; Mills, A.; Schellenberg, J. 2014: Cost-effectiveness of strategies to improve the utilization and provision of maternal and newborn health care in low-income and lower-middle-income countries: a systematic review Bmc Pregnancy and Childbirth 14: 243
Bartlett, L.; Weissman, E.; Gubin, R.; Patton-Molitors, R.; Friberg, I.K. 2014: The impact and cost of scaling up midwifery and obstetrics in 58 low- and middle-income countries Plos one 9(6): E98550
Newall, A.T.; Jit, M.; Hutubessy, R. 2014: Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines Pharmacoeconomics 32(6): 525-531
Johri, M.; Ako-Arrey, D. 2011: The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review Cost Effectiveness and Resource Allocation: C/E 9: 3
Venkatesh, K.K.; Becker, J.E.; Kumarasamy, N.; Nakamura, Y.M.; Mayer, K.H.; Losina, E.; Swaminathan, S.; Flanigan, T.P.; Walensky, R.P.; Freedberg, K.A. 2013: Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India Plos one 8(5): E64604
Kuznik, A.; Lamorde, M.; Nyabigambo, A.; Manabe, Y.C. 2013: Antenatal syphilis screening using point-of-care testing in Sub-Saharan African countries: a cost-effectiveness analysis Plos Medicine 10(11): E1001545
Mvundura, M.; Nundy, N.; Kilbourne-Brook, M.; Coffey, P.S. 2015: Estimating the hypothetical dual health impact and cost-effectiveness of the Woman's Condom in selected sub-Saharan African countries International Journal of Women's Health 7: 271-277
Adam, P.C.G.; de Wit, J.B.F.; Toskin, I.; Mathers, B.M.; Nashkhoev, M.; Zablotska, I.; Lyerla, R.; Rugg, D. 2009: Estimating levels of HIV testing, HIV prevention coverage, HIV knowledge, and condom use among men who have sex with men (MSM) in low-income and middle-income countries Journal of Acquired Immune Deficiency Syndromes 52 Suppl. 2: S143-S151
Seidman, G.; Atun, R. 2017: Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? a systematic review of evidence from low-income and middle-income countries Bmj Global Health 2(2): E000243
Drummond, M.F. 1985: Survey of cost-effectiveness and cost-benefit analyses in industrialized countries World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 38(4): 383-401
Walker, D. 2003: Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? Health Policy and Planning 18(1): 4-17
Bassett, I.V.; Govindasamy, D.; Erlwanger, A.S.; Hyle, E.P.; Kranzer, K.; van Schaik, N.; Noubary, F.; Paltiel, A.D.; Wood, R.; Walensky, R.P.; Losina, E.; Bekker, L.-G.; Freedberg, K.A. 2014: Mobile HIV screening in Cape Town, South Africa: clinical impact, cost and cost-effectiveness Plos one 9(1): E85197
Gomez, G.B.; Borquez, A.; Case, K.K.; Wheelock, A.; Vassall, A.; Hankins, C. 2013: The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies Plos Medicine 10(3): E1001401
Menzies, N.A.; Homsy, J.; Chang Pitter, J.Y.; Pitter, C.; Mermin, J.; Downing, R.; Finkbeiner, T.; Obonyo, J.; Kekitiinwa, A.; Tappero, J.; Blandford, J.M. 2009: Cost-effectiveness of routine rapid human immunodeficiency virus antibody testing before DNA-PCR testing for early diagnosis of infants in resource-limited settings Pediatric Infectious Disease Journal 28(9): 819-825